Skip to main content
Clinical Trials/NCT02219295
NCT02219295CompletedNot Applicable

Sensory and Gastrointestinal Impact of Taste Receptor Variants on Human Metabolism and Nutrition

German Institute of Human Nutrition2 sites in 1 country97 target enrollmentStarted: December 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
97
Locations
2
Primary Endpoint
Area under the curve (AUC): changes of expression levels of the sweet , bitter und umami taste receptors in humans in the upper bowel and responses of incretins to receptor agonists and antagonists

Study Overview

Brief Summary

We investigate the impact of taste receptors (sweet, bitter and umami) on human metabolism. There ist growing evidence, that components of the taste signalling system, including the taste receptor proteins , have important functions in the regulation of metabolic parameters in non-gustatory tissues.

Detailed Description

We apply different sweet, bitter and umami taste compounds in a single dose in the human intervention. We use substances as for instance glucose, sucrose,saccharin and lactisol in the sweet part, and substances from cabbage, beer or red endive in the bitter part. For umami we take glutamate.

Blood samples are collected at baseline and 6 times thereafter up to 3hours, to analyse the incretins GLP-1(glucagon-like peptide 1) and GIP(gastrointestinal polypeptide) and other peptide hormones as insulin and PYY(peptide tyrosin trosin) in human beings.

Gastrointestinal mucosa is taken by gastroscopy from the lower duodenum from study subjects for analysis for the presence or absence of functional taste receptors in gastrointestinal tissues.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Basic Science
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy persons

Exclusion Criteria

  • Tumor in history
  • Pregnancy
  • Severe illness in history
  • Bodymass index below 18

Outcomes

Primary Outcomes

Area under the curve (AUC): changes of expression levels of the sweet , bitter und umami taste receptors in humans in the upper bowel and responses of incretins to receptor agonists and antagonists

Time Frame: three years

measurement of incretins (GIP, GLP-1) and peptide hormones in human plasma after consumption of different sugars , sweeteners , bitter tasting ingredients of vegetables und umami. Measurement of expression levels in human intestinal mucosa before and after receptor stimulation

Secondary Outcomes

  • changes in the signalling cascade of the sweet receptor SGLT1 (sodium tranporter 1), changes of receptor expression(3 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. med. Andreas F. H. Pfeiffer

Prof. Dr. med.

German Institute of Human Nutrition

Study Sites (2)

Loading locations...

Similar Trials

SEGATROM: Sensory and Gastrointestinal... | Clinical Trial